IFN-α and lipopolysaccharide upregulate APOBEC3 mRNA through different signaling pathways

Journal of Immunology

Volumn 189, Issue 8, 2012, Pages 4088-4103

  Mehta, Harshini V ^a   Jones, Philip H ^a   Weiss, Jerrold P ^a   Okeoma, Chioma M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; BETA INTERFERON; CYTIDINE DEAMINASE; INTERFERON REGULATORY FACTOR 3; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE C; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERFERON PRODUCTION; MACROPHAGE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SYNTHESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; CELL LINE, TRANSFORMED; CYTIDINE DEAMINASE; DENDRITIC CELLS; HIV-1; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-ALPHA; INTRACELLULAR FLUID; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84867312684     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200777     Document Type: Article

References (119)

1. Bishop, K. N., R. K. Holmes, A. M. Sheehy, N. O. Davidson, S. J. Cho, and M. H. Malim. 2004. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14: 1392-1396. (Pubitemid 39081643)
2. Okeoma, C. M., N. Lovsin, B. M. Peterlin, and S. R. Ross. 2007. APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 445: 927-930.
3. Low, A., C. M. Okeoma, N. Lovsin, M. de las Heras, T. H. Taylor, B. M. Peterlin, S. R. Ross, and H. Fan. 2009. Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene. Virology 385: 455-463.
4. Chen, H., C. E. Lilley, Q. Yu, D. V. Lee, J. Chou, I. Narvaiza, N. R. Landau, and M. D. Weitzman. 2006. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr. Biol. 16: 480-485. (Pubitemid 43343708)
5. Holmes, R. K., F. A. Koning, K. N. Bishop, and M. H. Malim. 2007. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J. Biol. Chem. 282: 2587-2595. (Pubitemid 47076764)
6. Muckenfuss, H., M. Hamdorf, U. Held, M. Perkovic, J. Löwer, K. Cichutek, E. Flory, G. G. Schumann, and C. Münk. 2006. APOBEC3 proteins inhibit human LINE-1 retrotransposition. J. Biol. Chem. 281: 22161-22172. (Pubitemid 44181920)
7. OhAinle, M., J. A. Kerns, M. M. Li, H. S. Malik, and M. Emerman. 2008. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 4: 249-259.
8. Tan, L., P. T. Sarkis, T.Wang, C. Tian, and X. F. Yu. 2009. Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1. FASEB J. 23: 279-287.
9. Zhen, A., T. Wang, K. Zhao, Y. Xiong, and X. F. Yu. 2010. A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity. J. Virol. 84: 1902-1911.
10. Su, A. I., T. Wiltshire, S. Batalov, H. Lapp, K. A. Ching, D. Block, J. Zhang, R. Soden, M. Hayakawa, G. Kreiman, et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101: 6062-6067. (Pubitemid 38520528)
11. Conticello, S. G., R. S. Harris, and M. S. Neuberger. 2003. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 13: 2009-2013. (Pubitemid 37425213)
12. Marin, M., K. M. Rose, S. L. Kozak, and D. Kabat. 2003. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9: 1398-1403. (Pubitemid 37466189)
13. Sheehy, A. M., N. C. Gaddis, and M. H. Malim. 2003. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9: 1404-1407. (Pubitemid 37466190)
14. Yu, X., Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X. F. Yu. 2003. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302: 1056-1060. (Pubitemid 37386201)
15. Stopak, K., C. de Noronha, W. Yonemoto, and W. C. Greene. 2003. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12: 591-601. (Pubitemid 37222482)
16. Mehle, A., B. Strack, P. Ancuta, C. Zhang, M. McPike, and D. Gabuzda. 2004. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J. Biol. Chem. 279: 7792-7798. (Pubitemid 38294663)
17. Yu, Y., Z. Xiao, E. S. Ehrlich, X. Yu, and X. F. Yu. 2004. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 18: 2867-2872. (Pubitemid 39602305)
18. Harris, R. S., K. N. Bishop, A. M. Sheehy, H. M. Craig, S. K. Petersen-Mahrt, I. N. Watt, M. S. Neuberger, and M. H. Malim. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809. (Pubitemid 36724943)
19. Lecossier, D., F. Bouchonnet, F. Clavel, and A. J. Hance. 2003. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300: 1112. (Pubitemid 36583087)
20. Mangeat, B., P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424: 99-103. (Pubitemid 36834849)
21. Zhang, H., B. Yang, R. J. Pomerantz, C. Zhang, S. C. Arunachalam, and L. Gao. 2003. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424: 94-98. (Pubitemid 36834848)
22. Yu, Q., D. Chen, R. König, R. Mariani, D. Unutmaz, and N. R. Landau. 2004. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J. Biol. Chem. 279: 53379-53386. (Pubitemid 40051843)
23. Okeoma, C. M., A. L. Huegel, J. Lingappa, M. D. Feldman, and S. R. Ross. 2010. APOBEC3 proteins expressed in mammary epithelial cells are packaged into retroviruses and can restrict transmission of milk-borne virions. Cell Host Microbe 8: 534-543.
24. Peng, G., K. J. Lei, W. Jin, T. Greenwell-Wild, and S. M. Wahl. 2006. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med. 203: 41-46.
25. Sarkis, P. T., S. Ying, R. Xu, and X. F. Yu. 2006. STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha. J. Immunol. 177: 4530-4540. (Pubitemid 44469784)
26. Stopak, K. S., Y. L. Chiu, J. Kropp, R. M. Grant, and W. C. Greene. 2007. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J. Biol. Chem. 282: 3539-3546. (Pubitemid 47084447)
27. Ying, S., X. Zhang, P. T. Sarkis, R. Xu, and X. Yu. 2007. Cell-specific regulation of APOBEC3F by interferons. Acta Biochim. Biophys. Sin. (Shanghai) 39: 297-304. (Pubitemid 46625313)
28. Koning, F. A., E. N. Newman, E. Y. Kim, K. J. Kunstman, S. M. Wolinsky, and M. H. Malim. 2009. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 83: 9474-9485.
29. Okeoma, C. M., A. Low, W. Bailis, H. Y. Fan, B. M. Peterlin, and S. R. Ross. 2009. Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. J. Virol. 83: 3486-3495.
30. Bonvin, M., F. Achermann, I. Greeve, D. Stroka, A. Keogh, D. Inderbitzin, D. Candinas, P. Sommer, S. Wain-Hobson, J. P. Vartanian, and J. Greeve. 2006. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 43: 1364-1374. (Pubitemid 43980116)
31. Zhang, W., X. Zhang, C. Tian, T. Wang, P. T. Sarkis, Y. Fang, S. Zheng, X. F. Yu, and R. Xu. 2008. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression. Cell. Microbiol. 10: 112-121. (Pubitemid 350239060)
32. Xu, R., X. Zhang, W. Zhang, Y. Fang, S. Zheng, and X. F. Yu. 2007. Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma. Hepatology 46: 1810-1820.
33. Pestka, S., J. A. Langer, K. C. Zoon, and C. E. Samuel. 1987. Interferons and their actions. Annu. Rev. Biochem. 56: 727-777. (Pubitemid 17105465)
34. Platanias, L. C., S. Uddin, and O. R. Colamonici. 1994. Tyrosine phosphorylation of the alpha and beta subunits of the type I interferon receptor. Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein. J. Biol. Chem. 269: 17761-17764.
35. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
36. Qureshi, S. A., M. Salditt-Georgieff, and J. E. Darnell, Jr. 1995. Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3. Proc. Natl. Acad. Sci. USA 92: 3829-3833.
37. Akira, S., and S. Sato. 2003. Toll-like receptors and their signaling mechanisms. Scand. J. Infect. Dis. 35: 555-562. (Pubitemid 37336872)
38. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088. (Pubitemid 29001265)
39. Yamamoto, M., S. Sato, H. Hemmi, H. Sanjo, S. Uematsu, T. Kaisho, K. Hoshino, O. Takeuchi, M. Kobayashi, T. Fujita, et al. 2002. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420: 324-329. (Pubitemid 35398188)
40. May, M. J., and S. Ghosh. 1998. Signal transduction through NF-kappa B. Immunol. Today 19: 80-88.
41. Doyle, S., S. Vaidya, R. O'Connell, H. Dadgostar, P. Dempsey, T. Wu, G. Rao, R. Sun, M. Haberland, R. Modlin, and G. Cheng. 2002. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17: 251-263. (Pubitemid 35279547)
42. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511. (Pubitemid 38931765)
43. Uddin, S., B. Majchrzak, J. Woodson, P. Arunkumar, Y. Alsayed, R. Pine, P. R. Young, E. N. Fish, and L. C. Platanias. 1999. Activation of the p38 mitogen-activated protein kinase by type I interferons. J. Biol. Chem. 274: 30127-30131.
44. Arora, T., G. Floyd-Smith, M. J. Espy, and D. F. Jelinek. 1999. Dissociation between IFN-alpha-induced anti-viral and growth signaling pathways. J. Immunol. 162: 3289-3297. (Pubitemid 29313576)
45. Zhao, L. J., X. Hua, S. F. He, H. Ren, and Z. T. Qi. 2011. Interferon alpha regulates MAPK and STAT1 pathways in human hepatoma cells. Virol. J. 8: 157.
46. Chi, H., S. P. Barry, R. J. Roth, J. J. Wu, E. A. Jones, A. M. Bennett, and R. A. Flavell. 2006. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. USA 103: 2274-2279. (Pubitemid 43271660)
47. Dong, C., R. J. Davis, and R. A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20: 55-72. (Pubitemid 34293420)
48. Dumitru, C. D., J. D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis, J. H. Lin, C. Patriotis, N. A. Jenkins, N. G. Copeland, G. Kollias, and P. N. Tsichlis. 2000. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103: 1071-1083. (Pubitemid 32040907)
49. Chi, H., and R. A. Flavell. 2008. Acetylation of MKP-1 and the control of inflammation. Sci. Signal. 1: pe44.
50. Johnson, G. L., and R. Lapadat. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912. (Pubitemid 35425238)
51. Lawrence, M. C., K. McGlynn, B. Naziruddin, M. F. Levy, and M. H. Cobb. 2007. Differential regulation of CHOP-10/GADD153 gene expression by MAPK signaling in pancreatic beta-cells. Proc. Natl. Acad. Sci. USA 104: 11518-11525. (Pubitemid 47175045)
52. Guo, B., K. Inoki, M. Isono, H. Mori, K. Kanasaki, T. Sugimoto, S. Akiba, T. Sato, B. Yang, R. Kikkawa, et al. 2005. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells. Kidney Int. 68: 972-984. (Pubitemid 43246414)
53. Kreisberg, J. F., W. Yonemoto, and W. C. Greene. 2006. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J. Exp. Med. 203: 865-870.
54. Chen, H., L. W. Wang, Y. Q. Huang, and Z. J. Gong. 2010. Interferon-alpha Induces High Expression of APOBEC3G and STAT-1 in Vitro and in Vivo. Int. J. Mol. Sci. 11: 3501-3512.
55. Roberson, S. M., and W. S. Walker. 1988. Immortalization of cloned mouse splenic macrophages with a retrovirus containing the v-raf/mil and v-myc oncogenes. Cell. Immunol. 116: 341-351. (Pubitemid 18269313)
56. Mehta, H., M. Glogauer, S. Bécart, A. Altman, and K. M. Coggeshall. 2009. Adaptor protein SLAT modulates Fcgamma receptor-mediated phagocytosis in murine macrophages. J. Biol. Chem. 284: 11882-11891.
57. Hammer, K. D., M. Y. Yum, P. M. Dixon, and D. F. Birt. 2010. Identification of JAK-STAT pathways as important for the anti-inflammatory activity of a Hypericum perforatum fraction and bioactive constituents in RAW 264.7 mouse macrophages. Phytochemistry 71: 716-725.
58. Khorooshi, R., A. A. Babcock, and T. Owens. 2008. NF-kappaB-driven STAT2 and CCL2 expression in astrocytes in response to brain injury. J. Immunol. 181: 7284-7291.
59. Okeoma, C. M., M. Shen, and S. R. Ross. 2008. A novel block to mouse mammary tumor virus infection of lymphocytes in B10.BR mice. J. Virol. 82: 1314-1322.
60. Jones, P. H., H. V. Mehta, M. Maric, R. J. Roller, and C. M. Okeoma. 2012. Bone marrow stromal cell antigen 2 (BST-2) restricts mouse mammary tumor virus (MMTV) replication in vivo. Retrovirology 9: 10.
61. Jones, P. H., H. V. Mehta, and C. M. Okeoma. 2012. A novel role for APOBEC3: Susceptibility to sexual transmission of murine acquired immunodeficiency virus (mAIDS) is aggravated in APOBEC3 deficient mice. Retrovirology 9: 50.
62. Okeoma, C. M., J. Petersen, and S. R. Ross. 2009. Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection. J. Virol. 83: 3029-3038.
63. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, and R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921. (Pubitemid 24245635)
64. Auerbuch, V., D. G. Brockstedt, N. Meyer-Morse, M. O'Riordan, and D. A. Portnoy. 2004. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200: 527-533. (Pubitemid 39121909)
65. Oshiumi, H., M. Matsumoto, K. Funami, T. Akazawa, and T. Seya. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4: 161-167. (Pubitemid 36193018)
66. Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira. 2002. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169: 6668-6672. (Pubitemid 36899248)
67. Kawamoto, T., M. Ii, T. Kitazaki, Y. Iizawa, and H. Kimura. 2008. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur. J. Pharmacol. 584: 40-48.
68. Lanford, R. E., B. Guerra, H. Lee, D. Chavez, K. M. Brasky, and C. B. Bigger. 2006. Genomic response to interferon-alpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics. Hepatology 43: 961-972. (Pubitemid 43724621)
69. Rose, K. M., M. Marin, S. L. Kozak, and D. Kabat. 2004. Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus. J. Biol. Chem. 279: 41744-41749. (Pubitemid 39313620)
70. Kikkawa, U., K. Ogita, Y. Ono, Y. Asaoka, M. S. Shearman, T. Fujii, K. Ase, K. Sekiguchi, K. Igarashi, and Y. Nishizuka. 1987. The common structure and activities of four subspecies of rat brain protein kinase C family. FEBS Lett. 223: 212-216.
71. Carpenter, D., T. Jackson, and M. R. Hanley. 1987. Protein kinase Cs. Coping with a growing family. Nature 325: 107-108. (Pubitemid 17052294)
72. Gschwendt, M., H. J. Müller, K. Kielbassa, R. Zang, W. Kittstein, G. Rincke, and F. Marks. 1994. Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 199: 93-98.
73. Shoenfelt, J. L., and M. J. Fenton. 2006. TLR2- and TLR4-dependent activation of STAT1 serine phosphorylation in murine macrophages is protein kinase C-delta-independent. J. Endotoxin Res. 12: 231-240. (Pubitemid 47470166)
74. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376. (Pubitemid 37174535)
75. Gorina, R., M. Font-Nieves, L. Márquez-Kisinousky, T. Santalucia, and A. M. Planas. 2011. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways. Glia 59: 242-255.
76. Shepherd, E. G., Q. Zhao, S. E. Welty, T. N. Hansen, C. V. Smith, and Y. Liu. 2004. The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J. Biol. Chem. 279: 54023-54031. (Pubitemid 40053135)
77. Pion, M., A. Granelli-Piperno, B. Mangeat, R. Stalder, R. Correa, R. M. Steinman, and V. Piguet. 2006. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J. Exp. Med. 203: 2887-2893. (Pubitemid 46026166)
78. Baca-Regen, L., N. Heinzinger, M. Stevenson, and H. E. Gendelman. 1994. Alpha interferon-induced antiretroviral activities: restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes. J. Virol. 68: 7559-7565. (Pubitemid 24328815)
79. Krown, S. E., J. Y. Lee, L. Lin, M. A. Fischl, R. Ambinder, and J. H. Von Roenn. 2006. Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial. J. Acquir. Immune Defic. Syndr. 41: 149-153.
80. Goujon, C., and M. H. Malim. 2010. Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells. J. Virol. 84: 9254-9266.
81. Colamonici, O. R., P. Domanski, S. M. Sweitzer, A. Larner, and R. M. Buller. 1995. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J. Biol. Chem. 270: 15974-15978.
82. Basler, C. F., A. Mikulasova, L. Martinez-Sobrido, J. Paragas, E. Mühlberger, M. Bray, H. D. Klenk, P. Palese, and A. García-Sastre. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77: 7945-7956. (Pubitemid 36792791)
83. Foy, E., K. Li, C. Wang, R. Sumpter, Jr., M. Ikeda, S. M. Lemon, and M. Gale, Jr. 2003. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300: 1145-1148. (Pubitemid 36583099)
84. Lin, R., R. S. Noyce, S. E. Collins, R. D. Everett, and K. L. Mossman. 2004. The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J. Virol. 78: 1675-1684. (Pubitemid 38176700)
85. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738. (Pubitemid 33009951)
86. Pauli, E. K., M. Schmolke, H. Hofmann, C. Ehrhardt, E. Flory, C. Münk, and S. Ludwig. 2009. High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity. Retrovirology 6: 38.
87. Wang, Y. J., X. Wang, H. Zhang, L. Zhou, S. Liu, D. L. Kolson, L. Song, L. Ye, and W. Z. Ho. 2009. Expression and regulation of antiviral protein APOBEC3G in human neuronal cells. J. Neuroimmunol. 206: 14-21.
88. Guan, Z., S. Y. Buckman, L. D. Springer, and A. R. Morrison. 1999. Both p38alpha(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1beta in rat glomerular mesangial cells. J. Biol. Chem. 274: 36200-36206.
89. Hua, L. L., M. L. Zhao, M. Cosenza, M. O. Kim, H. Huang, H. B. Tanowitz, C. F. Brosnan, and S. C. Lee. 2002. Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFalpha expression in human fetal astrocytes. J. Neuroimmunol. 126: 180-189. (Pubitemid 34521743)
90. Lahti, A., U. Jalonen, H. Kankaanranta, and E. Moilanen. 2003. c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages. Mol. Pharmacol. 64: 308-315. (Pubitemid 36909994)
91. Chen, C., Y. H. Chen, and W. W. Lin. 1999. Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology 97: 124-129.
92. Chen, C. C., and J. K. Wang. 1999. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol. Pharmacol. 55: 481-488.
93. Bhat, N. R., D. L. Feinstein, Q. Shen, and A. N. Bhat. 2002. p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-beta, and activating transcription factor-2. J. Biol. Chem. 277: 29584-29592. (Pubitemid 41079247)
94. Guan, Z., L. D. Baier, and A. R. Morrison. 1997. p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta. J. Biol. Chem. 272: 8083-8089. (Pubitemid 27137376)
95. Chan, E. D., and D. W. Riches. 2001. IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. Am. J. Physiol. Cell Physiol. 280: C441-C450.
96. Chan, E. D., K. R. Morris, J. T. Belisle, P. Hill, L. K. Remigio, P. J. Brennan, and D. W. Riches. 2001. Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways. Infect. Immun. 69: 2001-2010. (Pubitemid 32239662)
97. Chan, E. D., B. W. Winston, S. T. Uh, M. W. Wynes, D. M. Rose, and D. W. Riches. 1999. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-gamma and TNF-alpha in mouse macrophages. J. Immunol. 162: 415-422. (Pubitemid 29018949)
98. Cho, M. K., S. H. Suh, and S. G. Kim. 2002. JunB/AP-1 and NF-kappa B-mediated induction of nitric oxide synthase by bovine type I collagen in serum-stimulated murine macrophages. Nitric Oxide 6: 319-332. (Pubitemid 34852376)
99. Yadav, V., X. Zhang, J. Liu, S. Estrem, S. Li, X. Q. Gong, S. Buchanan, J. R. Henry, J. J. Starling, and S. B Peng. 2012. Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to Vemurafenib in human B-RAF V600E mutant melanoma. J. Biol. Chem. 287: 28087-28098.
100. Su, N., L. Peng, B. Xia, Y. Zhao, A. Xu, J. Wang, X. Wang, and B. Jiang. 2012. Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer. Mol. Cancer 11: 43.
101. Massaoka, M. H., A. L. Matsuo, C. R. Figueiredo, C. F. Farias, N. Girola, D. C. Arruda, J. A. Scutti, P. Romoff, O. A. Favero, M. J. Ferreira, et al. 2012. Jacaranone induces apoptosis in melanoma cells via ROS-mediated downregulation of Akt and p38 MAPK activation and displays antitumor activity in vivo. PLoS ONE 7: e38698.
102. Huang, W., K. Hu, S. Luo, M. Zhang, C. Li, W. Jin, Y. Liu, G. E. Griffin, R. J. Shattock, and Q. Hu. 2012. Herpes simplex virus type 2 infection of human epithelial cells induces CXCL9 expression and CD4+ T cell migration via activation of p38-CCAAT/enhancer-binding protein-β pathway. J. Immunol. 188: 6247-6257.
103. Mansouri, S., M. Kutky, and K. A. Hudak. 2012. Pokeweed antiviral protein increases HIV-1 particle infectivity by activating the cellular mitogen activated protein kinase pathway. PLoS ONE 7: e36369.
104. Zheng, Q., R. Tao, H. Gao, J. Xu, S. Shang, and N. Zhao. 2012. HCMV-encoded UL128 enhances TNF-α and IL-6 expression and promotes PBMC proliferation through the MAPK/ERK pathway in vitro. Viral Immunol. 25: 98-105.
105. Chihara, T., M. Hashimoto, A. Osman, Y. Hiyoshi-Yoshidomi, I. Suzu, N. Chutiwitoonchai, M. Hiyoshi, S. Okada, and S. Suzu. 2012. HIV-1 proteins preferentially activate anti-inflammatory M2-type macrophages. J. Immunol. 188: 3620-3627.
106. Chew, T., R. Noyce, S. E. Collins, M. H. Hancock, and K. L. Mossman. 2009. Characterization of the interferon regulatory factor 3-mediated antiviral response in a cell line deficient for IFN production. Mol. Immunol. 46: 393-399.
107. Pine, S. O., M. J. McElrath, and P. Y. Bochud. 2009. Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS 23: 2387-2395.
108. Sirén, J., J. Pirhonen, I. Julkunen, and S. Matikainen. 2005. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J. Immunol. 174: 1932-1937.
109. Rhee, S. H., B. W. Jones, V. Toshchakov, S. N. Vogel, and M. J. Fenton. 2003. Toll-like receptors 2 and 4 activate STAT1 serine phosphorylation by distinct mechanisms in macrophages. J. Biol. Chem. 278: 22506-22512. (Pubitemid 36830305)
110. Bhatt, K. H., R. K. Pandey, Y. Dahiya, and A. Sodhi. 2010. Protein kinase Cdelta and protein tyrosine kinase regulate peptidoglycan-induced nuclear factor-kappaB activation and inducible nitric oxide synthase expression in mouse peritoneal macrophages in vitro. Mol. Immunol. 47: 861-870.
111. Kim, D. C., S. H. Kim, M. W. Jeong, N. I. Baek, and K. T. Kim. 2005. Effect of rottlerin, a PKC-delta inhibitor, on TLR-4-dependent activation of murine microglia. Biochem. Biophys. Res. Commun. 337: 110-115.
112. Kurt-Jones, E. A., L. Popova, L. Kwinn, L. M. Haynes, L. P. Jones, R. A. Tripp, E. E. Walsh, M. W. Freeman, D. T. Golenbock, L. J. Anderson, and R. W. Finberg. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1: 398-401.
113. Haynes, L. M., D. D. Moore, E. A. Kurt-Jones, R. W. Finberg, L. J. Anderson, and R. A. Tripp. 2001. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 75: 10730-10737. (Pubitemid 33031542)
114. Rassa, J. C., J. L. Meyers, Y. Zhang, R. Kudaravalli, and S. R. Ross. 2002. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc. Natl. Acad. Sci. USA 99: 2281-2286. (Pubitemid 34169052)
115. Burzyn, D., J. C. Rassa, D. Kim, I. Nepomnaschy, S. R. Ross, and I. Piazzon. 2004. Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J. Virol. 78: 576-584. (Pubitemid 38067579)
116. Otten, L. A., D. Finke, and H. Acha-Orbea. 2002. Can MMTV exploit TLR4? Trends Microbiol. 10: 303-305, discussion 305-306.
117. Triantafilou, K., and M. Triantafilou. 2004. Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through toll-like receptor 4. J. Virol. 78: 11313-11320. (Pubitemid 39299671)
118. Medzhitov, R., and D. Littman. 2008. HIV immunology needs a new direction. Nature 455: 591.
119. Doehle, B. P., F. Hladik, J. P. McNevin, M. J. McElrath, and M. Gale, Jr. 2009. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J. Virol. 83: 10395-10405.